Pieris Pharmaceuticals Research and Development Expenses 1970-1969 | PVLA
Pieris Pharmaceuticals research and development expenses from 1970 to 1969. Research and development expenses can be defined as an expense arising from studies and product development processes.
Pieris Pharmaceuticals Annual Research and Development Expenses
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Research and Development Expenses
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
